We are fortunate to have the support and expertise of the following individuals or institutions.
Institutional
Claudio Cuello (Transgenic rat model of AD)
Edith Hamel (Transgenic mouse model of AD)
Salah El Mestikawy (Glutamatergic abnormalities in AD)
Alain Gratton (Glutamate system)
Andrew Reader (PET methodology)
Jean Paul Soucy (PET methodology)
Alain Dagher (Glutamate / dopamine interactions)
Chawki Benkelfat (Glutamate / dopamine interactions)
Marie-Christine Guiot (Neuropathology of dementia)
N.P. Vasavan Nair (Geriatric Psychiatry – primary dementia prevention)
Pierre Etienne (Geriatric Psychiatry – primary dementia prevention)
René Désautels (Geriatric Psychiatry – primary dementia prevention)
Jeffrey Hall (Glutamatergic abnormalities in neurological diseases)
Eliane Kobayashi (Glutamatergic abnormalities in neurological diseases)
Marco Leyton (Glutamatergic abnormalities in addiction)
John Breitner (Geriatric Psychiatry – primary dementia prevention)
Judes Poirier (Genetics – primary dementia prevention)
Natasha Raja (Psychology – primary dementia prevention)
Patricia Belchior (Functional assessment)
Aurelie Labbe (Epidemiology, Biostatistics & Occupational Health)
Mallar Chakravarty (Neuroimaging)
Provincial
Gassan Massarweh (Radiochemistry) at University of Montreal
Pierre Bellec (Resting state connectivity) at University of Montreal
Jazna Kriz (AD neuroinflamation) at University of Montreal
Marc-André Bédard (Imaging cholinergic neurotransmission) at Université du Québec à Montréal
National
Shadreck Mzengeza (Radiochemistry) at University of Manitoba
Andrew Goertzen (PET-MRI systems)
Doris Doudet (PET methodology)
International
Alzheimer’s Disease Neuroimaging Initiative (ADNI, Data sharing)
Hyoung Ihl Kim (GIST, Korea translational PET research)
Simon Fristed Eskildsen (Aarhus University, Denmark: Structural MRI methodology)
Ona Wu (Harvard University, MRI methodology)
Lyinong Wu (Capital University, China: Genetics and Alzheimer’s disease)
Henrik Zetterberg (University of Gothenberg, Sweden, Fluid Biomarkers)
Kok Pin Ng (National Neuroscience Institute, Singapore, Neurology)